Krasny, L.; Wilding, C.P.; Perkins, E.; Arthur, A.; Guljar, N.; Jenks, A.D.; Fisher, C.; Judson, I.; Thway, K.; Jones, R.L.;
et al. Proteomic Profiling Identifies Co-Regulated Expression of Splicing Factors as a Characteristic Feature of Intravenous Leiomyomatosis. Cancers 2022, 14, 2907.
https://doi.org/10.3390/cancers14122907
AMA Style
Krasny L, Wilding CP, Perkins E, Arthur A, Guljar N, Jenks AD, Fisher C, Judson I, Thway K, Jones RL,
et al. Proteomic Profiling Identifies Co-Regulated Expression of Splicing Factors as a Characteristic Feature of Intravenous Leiomyomatosis. Cancers. 2022; 14(12):2907.
https://doi.org/10.3390/cancers14122907
Chicago/Turabian Style
Krasny, Lukas, Chris P. Wilding, Emma Perkins, Amani Arthur, Nafia Guljar, Andrew D. Jenks, Cyril Fisher, Ian Judson, Khin Thway, Robin L. Jones,
and et al. 2022. "Proteomic Profiling Identifies Co-Regulated Expression of Splicing Factors as a Characteristic Feature of Intravenous Leiomyomatosis" Cancers 14, no. 12: 2907.
https://doi.org/10.3390/cancers14122907
APA Style
Krasny, L., Wilding, C. P., Perkins, E., Arthur, A., Guljar, N., Jenks, A. D., Fisher, C., Judson, I., Thway, K., Jones, R. L., & Huang, P. H.
(2022). Proteomic Profiling Identifies Co-Regulated Expression of Splicing Factors as a Characteristic Feature of Intravenous Leiomyomatosis. Cancers, 14(12), 2907.
https://doi.org/10.3390/cancers14122907
